Brighton Jones LLC’s AbbVie ABBV Stock Holding History

Brighton Jones LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.06M	Buy	+32,484	New	+$7.21M	0.16%	87
2025 Q4	–	Sell	-28,557	Closed	-$6.61M	–	57
2025 Q3	$6.61M	Buy	28,557 +537	+2%	+$109K	0.16%	82
2025 Q2	$5.2M	Buy	28,020 +670	+2%	+$125K	0.14%	93
2025 Q1	$5.73M	Buy	27,350 +4,438	+19%	+$863K	0.18%	74
2024 Q4	$4.07M	Buy	22,912 +3,401	+17%	+$625K	0.12%	100
2024 Q3	$3.85M	Sell	19,511 -210	-1%	-$39.2K	0.14%	83
2024 Q2	$3.38M	Buy	19,721 +477	+2%	+$79K	0.11%	96
2024 Q1	$3.5M	Buy	19,244 +2,387	+14%	+$411K	0.13%	90
2023 Q4	$2.61M	Sell	16,857 -1,270	-7%	-$185K	0.11%	104
2023 Q3	$2.7M	Buy	18,127 +2,168	+14%	+$318K	0.14%	90
2023 Q2	$2.15M	Buy	15,959 +430	+3%	+$63.1K	0.11%	112
2023 Q1	$2.47M	Buy	15,529 +498	+3%	+$76.1K	0.14%	92
2022 Q4	$2.43M	Buy	15,031 +167	+1%	+$25.6K	0.15%	86
2022 Q3	$2M	Buy	14,864 +660	+5%	+$94.7K	0.12%	97
2022 Q2	$2.17M	Sell	14,204 -29	-0.2%	-$4.43K	0.13%	94
2022 Q1	$2.31M	Buy	14,233 +629	+5%	+$91.4K	0.11%	99
2021 Q4	$1.84M	Buy	13,604 +2,769	+26%	+$327K	0.09%	109
2021 Q3	$1.17M	Buy	10,835 +1,575	+17%	+$180K	0.06%	141
2021 Q2	$1.04M	Sell	9,260 -1,624	-15%	-$183K	0.05%	151
2021 Q1	$1.18M	Buy	10,884 +1,665	+18%	+$178K	0.07%	129
2020 Q4	$988K	Sell	9,219 -152	-2%	-$14.6K	0.06%	134
2020 Q3	$821K	Buy	9,371 +116	+1%	+$10.9K	0.06%	136
2020 Q2	$909K	Buy	9,255 +301	+3%	+$26.5K	0.07%	116
2020 Q1	$682K	Sell	8,954 -1,017	-10%	-$86.6K	0.07%	126
2019 Q4	$883K	Sell	9,971 -15	-0.2%	-$1.25K	0.09%	128
2019 Q3	$756K	Buy	9,986 +131	+1%	+$8.98K	0.09%	123
2019 Q2	$717K	Buy	9,855 +333	+3%	+$26.2K	0.08%	128
2019 Q1	$767K	Sell	9,522 -252	-3%	-$20.6K	0.09%	123
2018 Q4	$901K	Buy	9,774 +132	+1%	+$11.6K	0.13%	94
2018 Q3	$912K	Buy	9,642 +739	+8%	+$70.1K	0.11%	101
2018 Q2	$825K	Buy	8,903 +2,111	+31%	+$206K	0.11%	115
2018 Q1	$643K	Sell	6,792 -463	-6%	-$50.9K	0.09%	129
2017 Q4	$702K	Buy	7,255 +258	+4%	+$24.3K	0.09%	117
2017 Q3	$622K	Buy	6,997 +114	+2%	+$8.68K	0.08%	128
2017 Q2	$499K	Buy	+6,883	New	+$463K	0.07%	134
2016 Q4	–	Sell	-7,073	Closed	-$446K	–	100
2016 Q3	$446K	Sell	7,073 -25	-0.4%	-$1.62K	0.07%	136
2016 Q2	$439K	Sell	7,098 -1,676	-19%	-$102K	0.08%	121
2016 Q1	$501K	Buy	8,774 +1,092	+14%	+$60.9K	0.09%	108
2015 Q4	$455K	Buy	7,682 +247	+3%	+$14.2K	0.09%	114
2015 Q3	$405K	Buy	7,435 +747	+11%	+$48.6K	0.09%	116
2015 Q2	$449K	Sell	6,688 -469	-7%	-$30.6K	0.1%	103
2015 Q1	$419K	Sell	7,157 -486	-6%	-$29.4K	0.09%	109
2014 Q4	$500K	Sell	7,643 -4,423	-37%	-$279K	0.11%	102
2014 Q3	$697K	Buy	12,066 +4,844	+67%	+$269K	0.16%	76
2014 Q2	$408K	Sell	7,222 -1,425	-16%	-$74.8K	0.09%	112
2014 Q1	$444K	Sell	8,647 -881	-9%	-$44.5K	0.1%	105
2013 Q4	$493K	Sell	9,528 -3,770	-28%	-$185K	0.11%	94
2013 Q3	$595K	Buy	13,298 +6,170	+87%	+$274K	0.16%	66
2013 Q2	$295K	Buy	+7,128	New	+$312K	0.09%	87

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brighton Jones LLC's ABBV Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in AbbVie (ABBV) in Q1 2026: 32,484 shares worth $7.06M. The stake represents 0.16% of the portfolio and ranks #87 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in ABBV as recently as Q3 2025.

Brighton Jones LLC first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Brighton Jones LLC held 32,484 shares of AbbVie worth $7.06M as of Q1 2026.
AbbVie was a new Brighton Jones LLC position in Q1 2026.
AbbVie made up 0.16% of Brighton Jones LLC's portfolio in Q1 2026, its #87 holding.
Brighton Jones LLC first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.